Sulfinpyrazone is a uricosuric medication used to treat gout. It also sometimes is used to reduce platelet aggregation by inhibiting degranulation of platelets which reduces the release of ADP and thromboxane. Like other uricosurics sulfinpyrazone works by competitively inhibiting uric acid reabsorption in the proximal tubule of the kidney.
This page contains content from the copyrighted Wikipedia article "Sulfinpyrazone"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
